- Home
- ZH vs ABSI Comparison
ZH vs ABSI Comparison
Compare ZH & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZH
- ABSI
- Stock Information
- Founded
- ZH 2011
- ABSI 2011
- Country
- ZH China
- ABSI United States
- Employees
- ZH N/A
- ABSI N/A
- Industry
- ZH Business Services
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ZH Consumer Discretionary
- ABSI Health Care
- Exchange
- ZH Nasdaq
- ABSI Nasdaq
- Market Cap
- ZH 502.7M
- ABSI 318.2M
- IPO Year
- ZH 2021
- ABSI 2021
- Fundamental
- Price
- ZH $5.20
- ABSI $2.95
- Analyst Decision
- ZH Strong Buy
- ABSI Strong Buy
- Analyst Count
- ZH 2
- ABSI 7
- Target Price
- ZH $5.65
- ABSI $8.57
- AVG Volume (30 Days)
- ZH 1.7M
- ABSI 5.2M
- Earning Date
- ZH 03-26-2025
- ABSI 03-18-2025
- Dividend Yield
- ZH N/A
- ABSI N/A
- EPS Growth
- ZH N/A
- ABSI N/A
- EPS
- ZH N/A
- ABSI N/A
- Revenue
- ZH $552,853,374.00
- ABSI $4,207,000.00
- Revenue This Year
- ZH N/A
- ABSI $7.92
- Revenue Next Year
- ZH $8.26
- ABSI $162.34
- P/E Ratio
- ZH N/A
- ABSI N/A
- Revenue Growth
- ZH N/A
- ABSI N/A
- 52 Week Low
- ZH $2.55
- ABSI $2.45
- 52 Week High
- ZH $6.32
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- ZH 56.31
- ABSI 33.34
- Support Level
- ZH $5.08
- ABSI $3.02
- Resistance Level
- ZH $5.87
- ABSI $3.41
- Average True Range (ATR)
- ZH 0.49
- ABSI 0.37
- MACD
- ZH -0.06
- ABSI -0.21
- Stochastic Oscillator
- ZH 33.73
- ABSI 3.18
About ZH Zhihu Inc. (every two of each representing one ordinary share)
Zhihu Inc is predominantly engaged in the operation of one online content community and monetizes through paid membership services, advertising services, content-commerce solutions services, and vocational training in China. It generates revenues from Advertising services, Paid membership services, Content-commerce solutions, and Others. It derives all its revenues within China.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.